FOR LABORATORY RESEARCH ONLY Direct quotations · Minimum 1 box

Cell & tissue research

Thymosin beta 4 and cardiac-cell survival: full-length peptide research

Cell and mouse experiments linked thymosin beta 4 with ILK and Akt signaling.

Preclinical studyPaper year: 2004Thymosin beta 4

01 / DESIGN

What was studied?

The study examined embryonic and postnatal cardiac cells and a mouse coronary-ligation model. Researchers investigated cell migration, survival and signaling involving PINCH, integrin-linked kinase and Akt.

02 / FINDINGS

What did the researchers report?

Thymosin beta 4 was associated with improved cell survival and migration in the investigated systems. In mice, the authors reported changes in ILK/Akt activity and early survival of heart muscle cells, alongside cardiac-function observations.

03 / LIMITS

How should it be interpreted?

This paper concerns thymosin beta 4, not an analytically established equivalent of every product called TB-500. Cell and mouse findings do not demonstrate a human cardiac treatment. Peptide sequence, modifications and study context matter before any material comparison.

Voltera Peptide editorial reading note. Based on the linked source record. Methods and corrections.

WhatsApp ↗